^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
IOpener®

Company:
PamGene
Type:
CE Marked

Details

Evidence
The IOpener® is a blood-based diagnostic test that supports immunotherapy treatment selection. This peptide microarray-based test measures the activity of kinases in peripheral blood mononuclear cell isolated from a single tube of blood from a patient to determine the likelihood of responding to immunotherapy. The IOpener™ test is currently available as in-house developed test and is in the final phase of clinical validation for CE-IVD certification.
Cancer:
Melanoma, Non Small Cell Lung Cancer
Method:
Liquid biopsy
Approvals
Date
Cancer
Gene
Drug
By
07/05/22
CE
07/21/22
CE